{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:00:00Z","timestamp":1784091600902,"version":"3.55.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"MSIP","doi-asserted-by":"publisher","award":["2019R1C1C1009875"],"award-info":[{"award-number":["2019R1C1C1009875"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"MSIP","doi-asserted-by":"publisher","award":["2022R1C1C1006807"],"award-info":[{"award-number":["2022R1C1C1006807"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Myasthenia gravis (MG) is an autoimmune disorder that affects the neuromuscular junctions, resulting in muscle weakness and fatigue. Muscle weakness, restricted mobility, and frequent use of corticosteroids in patients with MG may predispose them to a higher risk of fractures. However, studies on the impact of MG on bone health and the associated fracture risk are scarce. Utilizing claim database of the Korean National Health Insurance Service collected between 2002 and 2020, we compared the risk of major osteoporotic fracture between 23\u2009118 patients with MG and 115\u2009590 individuals as an age- and sex-matched control group using multivariable Cox proportional hazard models. Over a median follow-up duration of 5.58\u00a0years, the MG group (mean age 53.7\u00a0years; 55% women) had higher risk of major osteoporotic fracture compared with controls (incidence rate 13.59 versus 9.74 per 10\u2009000 person-years), which remained independent of age, sex, comorbidities, drug use including anti-osteoporotic agents, and previous fracture history (adjusted hazard ratio [aHR] 1.19, P\u2009&amp;lt;\u20090.001; subdistributed HR 1.14, P\u2009&amp;lt;\u20090.001 adjusted for mortality as competing risk). Subgroup analyses showed a greater association between MG and major osteoporotic fracture risk in younger (age 50 or younger) than older individuals (aHR 1.34 vs. 1.17) and in men compared with women (aHR 1.32 vs. 1.15; P for interaction &amp;lt;\u20090.05 for all). An imminent divergence of the fracture risk curve between MG and controls was observed for vertebral fracture, while there was time delay for non-vertebral sites, showing site-specific association. Factors associated with higher fracture risk in patients with MG were older age, female gender, high dose glucocorticoid use (&amp;gt;7.5\u00a0mg\/day), immunosuppressant use, and previous history of fracture. In summary, patients with MG had higher risk of major osteoporotic fracture compared with controls, which calls further preventive actions in this patient group.<\/jats:p>","DOI":"10.1093\/jbmr\/zjae043","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T11:12:25Z","timestamp":1710241945000},"page":"688-696","source":"Crossref","is-referenced-by-count":14,"title":["Risk of fracture in patients with myasthenia gravis: a nationwide cohort study in Korea"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5757-6233","authenticated-orcid":false,"given":"Hye-Sun","family":"Park","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine , Seoul 06273 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6248-3111","authenticated-orcid":false,"given":"Kyoungsu","family":"Kim","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine , Seoul 03722 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Heui","family":"Yu","sequence":"additional","affiliation":[{"name":"SENTINEL Team , Division of Endocrinology, Department of Internal Medicine, , Seoul 03722 , South Korea"},{"name":"Yonsei University College of Medicine , Division of Endocrinology, Department of Internal Medicine, , Seoul 03722 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Young","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine , Seoul 03722 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-5638","authenticated-orcid":false,"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine , Seoul 03722 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yonsei University College of Medicine , Seoul 03722 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine , Seoul 03722 , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"issue":"11","key":"2024072411362487900_ref1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"2024072411362487900_ref2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JND-140045","article-title":"The epidemiology of neuromuscular disorders: a comprehensive overview of the literature","volume":"2","author":"Deenen","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"8","key":"2024072411362487900_ref3","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3346\/jkms.2011.26.8.1087","article-title":"Incidence and mortality following hip fracture in Korea","volume":"26","author":"Yoon","year":"2011","journal-title":"J Korean Med Sci"},{"issue":"8","key":"2024072411362487900_ref4","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10072-017-2964-z","article-title":"Negative impact of high cumulative glucocorticoid dose on bone metabolism of patients with myasthenia gravis","volume":"38","author":"Braz","year":"2017","journal-title":"Neurol Sci"},{"issue":"12","key":"2024072411362487900_ref5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.0000000000000804","article-title":"Increased risk of osteoporosis in patients with myasthenia gravis: a population-based cohort study","volume":"83","author":"Yeh","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"2024072411362487900_ref6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00198-012-1970-5","article-title":"Fracture rate in patients with myasthenia gravis: the general practice research database","volume":"24","author":"Pouwels","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"2024072411362487900_ref7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00774-011-0280-x","article-title":"Burden of osteoporosis in adults in Korea: a national health insurance database study","volume":"30","author":"Choi","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2024072411362487900_ref8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3349\/ymj.2016.57.2.419","article-title":"The epidemiology of myasthenia gravis in Korea","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med J"},{"issue":"11","key":"2024072411362487900_ref9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"1","key":"2024072411362487900_ref10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3803\/EnM.2023.102","article-title":"Big data research in the field of endocrine diseases using the Korean National Health Information Database","volume":"38","author":"Cho","year":"2023","journal-title":"Endocrinol Metab"},{"issue":"10","key":"2024072411362487900_ref11","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/jbmr.3807","article-title":"The design and validation of a new algorithm to identify incident fractures in administrative claims data","volume":"34","author":"Wright","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"446","key":"2024072411362487900_ref12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"2024072411362487900_ref13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JND-200612","article-title":"Fracture risk in patients with myasthenia gravis: a population-based cohort study","volume":"8","author":"Kassardjian","year":"2021","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"2024072411362487900_ref14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00441-009-0871-1","article-title":"Expression of non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis","volume":"338","author":"En-Nosse","year":"2009","journal-title":"Cell Tissue Res"},{"issue":"8","key":"2024072411362487900_ref15","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/jbmr.4024","article-title":"Brain-derived acetylcholine maintains peak bone mass in adult female mice","volume":"35","author":"Ma","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024072411362487900_ref16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.febslet.2010.01.001","article-title":"Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts","volume":"584","author":"Sato","year":"2010","journal-title":"FEBS Lett"},{"issue":"2","key":"2024072411362487900_ref17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol Clin"},{"issue":"1","key":"2024072411362487900_ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","article-title":"Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives","volume":"1","author":"Seibel","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2024072411362487900_ref19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"2024072411362487900_ref20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2362.1996.00170.x","article-title":"Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation","volume":"26","author":"Thiebaud","year":"1996","journal-title":"Eur J Clin Investig"},{"issue":"23","key":"2024072411362487900_ref21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236085","article-title":"Azathioprine has a deleterious effect on the bone health of mice with DSS-induced inflammatory bowel disease","volume":"20","author":"Morgan","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"58","key":"2024072411362487900_ref22","doi-asserted-by":"crossref","first-page":"98163","DOI":"10.18632\/oncotarget.21000","article-title":"Cyclophosphamide causes osteoporosis in C57BL\/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"2024072411362487900_ref23","volume":"9","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"2024072411362487900_ref24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol"},{"issue":"1","key":"2024072411362487900_ref25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: a prospective study","volume":"86","author":"Schwartz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9183","key":"2024072411362487900_ref26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","article-title":"High blood pressure and bone-mineral loss in elderly white women: a prospective study","volume":"354","author":"Cappuccio","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"2024072411362487900_ref27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1507\/endocrj.49.211","article-title":"Plasma lipids and osteoporosis in postmenopausal women","volume":"49","author":"Yamaguchi","year":"2002","journal-title":"Endocr J"},{"issue":"2","key":"2024072411362487900_ref28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mus.26356","article-title":"Muscle weakness and functional disability in patients with myasthenia gravis","volume":"59","author":"Vinge","year":"2019","journal-title":"Muscle Nerve"},{"issue":"11","key":"2024072411362487900_ref29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/jpm11111139","article-title":"Assessment of sarcopenia and obesity in patients with myasthenia gravis using dual-energy x-ray absorptiometry: a cross-sectional study","volume":"11","author":"Chang","year":"2021","journal-title":"J Pers Med"},{"issue":"4","key":"2024072411362487900_ref30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3233\/JND-210637","article-title":"Free-living physical activity and sedentary behaviour in autoimmune myasthenia gravis: a cross-sectional study","volume":"8","author":"Birnbaum","year":"2021","journal-title":"J Neuromuscul Dis."},{"issue":"2","key":"2024072411362487900_ref31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","article-title":"The science and therapy of glucocorticoid-induced bone loss","volume":"27","author":"Lane","year":"1998","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2024072411362487900_ref32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/OARRR.S282606","article-title":"Understanding and managing corticosteroid-induced osteoporosis","volume":"13","author":"Kobza","year":"2021","journal-title":"Open Access Rheumatol"},{"issue":"4","key":"2024072411362487900_ref33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s40120-022-00383-3","article-title":"Physician-reported perspectives on myasthenia gravis in the United States: a real-world survey","volume":"11","author":"Mahic","year":"2022","journal-title":"Neurol Ther"},{"key":"2024072411362487900_ref34","article-title":"Epidemiological and clinical characteristics of myasthenia gravis in Korea","volume":"15","author":"Lee","journal-title":"J Korean Neurol Assoc"},{"issue":"5","key":"2024072411362487900_ref35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-0404.2001.103005320.x","article-title":"Osteoporosis prevention in myasthenia gravis: a reminder","volume":"103","author":"Lewis","year":"2001","journal-title":"Acta Neurol Scand"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjae043\/57330838\/zjae043.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/6\/688\/58622088\/zjae043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/6\/688\/58622088\/zjae043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T02:40:17Z","timestamp":1721875217000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/39\/6\/688\/7626432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3,12]]},"published-print":{"date-parts":[[2024,7,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjae043","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,12]]}}}